The first consignments of the COVID vaccine produced by Johnson & Johnson began arriving in European Union countries on Monday, EU officials and the company have announced.
The EU is expected to receive 55 million doses of the long-awaited vaccine by June.
The vaccine, which Malta has reserved 250,000 doses of, was approved for use by the EMA in March.
It comes as Malta’s vaccine program continues to roar ahead of those of its neighbours. On Saturday, Deputy Prime Minister and Minister for Health Chris Fearne announced that the country is projected to receive herd immunity by the end of June.
So far, a total of 244,718 COVID vaccine doses have been administered in Malta, of which 71,481 were second doses.
The Johnson & Johnson vaccine is produced by Janssen, a Belgium-based subsidiary of the US pharma giants.
It is notable in that it is the first which is effective after a single dose, thus simplifying its rollout.
A clinical trial has shown the vaccine to have an efficacy rate of 67 per cent.
Apartment price level in St Julian’s and Ta’ Xbiex jump 14% in the span of a year
NSO statistics shows that apartment prices in Sliema are 61% above the national average
Uri Poliavich: Philanthropy, education and the Yael Foundation
How Uri Poliavich turned entrepreneurial principles into structural giving across 145 institutions in 48 countries
MFSA hikes maximum base fines for banks from €150,000 to €12.5 million
MFSA updates system used to calculate administrative penalties for banks